In this Healio Video Perspective from the ESCRS winter meeting, Harminder S. Dua, MD, PhD, professor of ophthalmology at the University of Nottingham, discusses the implications of Dua’s layer in ...
The FDA has accepted for review the New Drug Application for SYD-101 (atropine sulfate) to slow the progression of myopia in children.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback